Loading…
Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides
Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Pr...
Saved in:
Published in: | Archivum Immunologiae et Therapiae Experimentalis 2009-10, Vol.57 (5), p.383-391 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3 |
container_end_page | 391 |
container_issue | 5 |
container_start_page | 383 |
container_title | Archivum Immunologiae et Therapiae Experimentalis |
container_volume | 57 |
creator | Kaca, Wiesław Arabski, Michał Ph.D Fudała, Rafał Holmström, Eva Sjöholm, Anders Weintraub, Andrej Futoma-Kołoch, Bożena Bugla-Płoskońska, Gabriela Doroszkiewicz, Włodzimierz |
description | Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and Methods The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway. |
doi_str_mv | 10.1007/s00005-009-0043-8 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_556241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67606498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3</originalsourceid><addsrcrecordid>eNp9kV2L1TAQhoMo7tnVH-CNFi-8q07afDSXsqyucEBBD3gXknZ6Tta2qUmrnH9vSssuCJowJGSeeZPMS8gLCm8pgHwXIQ2eA6gUrMyrR2RHhaA5U1Q-JruUZTkI9f2CXMZ4tzCcsqfkgioJUhZ0Rw63c2-GrPb92GGPw5SZenK_zOT8kNlzFnvvp1NmhiYLfj6esi_BTzjHrHfBWNe5mHVu9KPvztHU9ckE12B8Rp60pov4fFuvyOHDzbfr23z_-eOn6_f7vOasnHKlmEgPAmqaRnBRUGgLVQlqsJAgWgOMS0OtZcBbQCkst4BGqJIhty2Y8orkq278jeNs9Rhcb8JZe-P0dvQj7VDzpM5o4vf_5Lt5TGFTLAUNpqtESTW3SDVrS9S24kbz2tYlb0RVNWWSe7PKjcH_nDFOunexxq4zA_o5aiEFCKaqBL7-C7zzcxhSa3QlFVQqtSFBdIXq4GMM2N4_j4Je_Nar3zr5rRcv9SL8chOebY_NQ8VmcAKK7ccpNRwxPNz8P9VXa1FrvDbH4KI-fC2AlkCFLEWafwAcb7-J</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>879089651</pqid></control><display><type>article</type><title>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</title><source>Springer Link</source><creator>Kaca, Wiesław ; Arabski, Michał Ph.D ; Fudała, Rafał ; Holmström, Eva ; Sjöholm, Anders ; Weintraub, Andrej ; Futoma-Kołoch, Bożena ; Bugla-Płoskońska, Gabriela ; Doroszkiewicz, Włodzimierz</creator><creatorcontrib>Kaca, Wiesław ; Arabski, Michał Ph.D ; Fudała, Rafał ; Holmström, Eva ; Sjöholm, Anders ; Weintraub, Andrej ; Futoma-Kołoch, Bożena ; Bugla-Płoskońska, Gabriela ; Doroszkiewicz, Włodzimierz</creatorcontrib><description>Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and Methods The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.</description><identifier>ISSN: 0004-069X</identifier><identifier>EISSN: 1661-4917</identifier><identifier>DOI: 10.1007/s00005-009-0043-8</identifier><identifier>PMID: 19707721</identifier><language>eng</language><publisher>Basel: Basel : SP Birkhäuser Verlag Basel</publisher><subject>Bacteria ; Bacterial Outer Membrane Proteins - immunology ; Bacterial Outer Membrane Proteins - isolation & purification ; Bacteriology ; Basic Medicine ; Biomedical and Life Sciences ; Biomedicine ; complement ; Complement Activation - drug effects ; Complement Activation - immunology ; Complement C3 - immunology ; Complement System Proteins - immunology ; Humans ; Immunologi inom det medicinska området ; Immunology ; Immunology in the medical area ; lipopolysaccharide ; Lipopolysaccharides - immunology ; Lipopolysaccharides - pharmacology ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Medicinska och farmaceutiska grundvetenskaper ; Microbial Sensitivity Tests ; Microbiology in the medical area ; Mikrobiologi inom det medicinska området ; Original Article ; outer-membrane ; outer-membrane protein ; Pharmacology/Toxicology ; protein ; Proteins ; Proteus Infections - immunology ; Proteus mirabilis ; Proteus mirabilis - chemistry ; Proteus mirabilis - immunology ; Serum - chemistry ; Serum - immunology</subject><ispartof>Archivum Immunologiae et Therapiae Experimentalis, 2009-10, Vol.57 (5), p.383-391</ispartof><rights>L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3</citedby><cites>FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19707721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/1476805$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:119264790$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaca, Wiesław</creatorcontrib><creatorcontrib>Arabski, Michał Ph.D</creatorcontrib><creatorcontrib>Fudała, Rafał</creatorcontrib><creatorcontrib>Holmström, Eva</creatorcontrib><creatorcontrib>Sjöholm, Anders</creatorcontrib><creatorcontrib>Weintraub, Andrej</creatorcontrib><creatorcontrib>Futoma-Kołoch, Bożena</creatorcontrib><creatorcontrib>Bugla-Płoskońska, Gabriela</creatorcontrib><creatorcontrib>Doroszkiewicz, Włodzimierz</creatorcontrib><title>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</title><title>Archivum Immunologiae et Therapiae Experimentalis</title><addtitle>Arch. Immunol. Ther. Exp</addtitle><addtitle>Arch Immunol Ther Exp (Warsz)</addtitle><description>Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and Methods The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.</description><subject>Bacteria</subject><subject>Bacterial Outer Membrane Proteins - immunology</subject><subject>Bacterial Outer Membrane Proteins - isolation & purification</subject><subject>Bacteriology</subject><subject>Basic Medicine</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>complement</subject><subject>Complement Activation - drug effects</subject><subject>Complement Activation - immunology</subject><subject>Complement C3 - immunology</subject><subject>Complement System Proteins - immunology</subject><subject>Humans</subject><subject>Immunologi inom det medicinska området</subject><subject>Immunology</subject><subject>Immunology in the medical area</subject><subject>lipopolysaccharide</subject><subject>Lipopolysaccharides - immunology</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Medical and Health Sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicinska och farmaceutiska grundvetenskaper</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology in the medical area</subject><subject>Mikrobiologi inom det medicinska området</subject><subject>Original Article</subject><subject>outer-membrane</subject><subject>outer-membrane protein</subject><subject>Pharmacology/Toxicology</subject><subject>protein</subject><subject>Proteins</subject><subject>Proteus Infections - immunology</subject><subject>Proteus mirabilis</subject><subject>Proteus mirabilis - chemistry</subject><subject>Proteus mirabilis - immunology</subject><subject>Serum - chemistry</subject><subject>Serum - immunology</subject><issn>0004-069X</issn><issn>1661-4917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kV2L1TAQhoMo7tnVH-CNFi-8q07afDSXsqyucEBBD3gXknZ6Tta2qUmrnH9vSssuCJowJGSeeZPMS8gLCm8pgHwXIQ2eA6gUrMyrR2RHhaA5U1Q-JruUZTkI9f2CXMZ4tzCcsqfkgioJUhZ0Rw63c2-GrPb92GGPw5SZenK_zOT8kNlzFnvvp1NmhiYLfj6esi_BTzjHrHfBWNe5mHVu9KPvztHU9ckE12B8Rp60pov4fFuvyOHDzbfr23z_-eOn6_f7vOasnHKlmEgPAmqaRnBRUGgLVQlqsJAgWgOMS0OtZcBbQCkst4BGqJIhty2Y8orkq278jeNs9Rhcb8JZe-P0dvQj7VDzpM5o4vf_5Lt5TGFTLAUNpqtESTW3SDVrS9S24kbz2tYlb0RVNWWSe7PKjcH_nDFOunexxq4zA_o5aiEFCKaqBL7-C7zzcxhSa3QlFVQqtSFBdIXq4GMM2N4_j4Je_Nar3zr5rRcv9SL8chOebY_NQ8VmcAKK7ccpNRwxPNz8P9VXa1FrvDbH4KI-fC2AlkCFLEWafwAcb7-J</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Kaca, Wiesław</creator><creator>Arabski, Michał Ph.D</creator><creator>Fudała, Rafał</creator><creator>Holmström, Eva</creator><creator>Sjöholm, Anders</creator><creator>Weintraub, Andrej</creator><creator>Futoma-Kołoch, Bożena</creator><creator>Bugla-Płoskońska, Gabriela</creator><creator>Doroszkiewicz, Włodzimierz</creator><general>Basel : SP Birkhäuser Verlag Basel</general><general>SP Birkhäuser Verlag Basel</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D95</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20091001</creationdate><title>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</title><author>Kaca, Wiesław ; Arabski, Michał Ph.D ; Fudała, Rafał ; Holmström, Eva ; Sjöholm, Anders ; Weintraub, Andrej ; Futoma-Kołoch, Bożena ; Bugla-Płoskońska, Gabriela ; Doroszkiewicz, Włodzimierz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Bacteria</topic><topic>Bacterial Outer Membrane Proteins - immunology</topic><topic>Bacterial Outer Membrane Proteins - isolation & purification</topic><topic>Bacteriology</topic><topic>Basic Medicine</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>complement</topic><topic>Complement Activation - drug effects</topic><topic>Complement Activation - immunology</topic><topic>Complement C3 - immunology</topic><topic>Complement System Proteins - immunology</topic><topic>Humans</topic><topic>Immunologi inom det medicinska området</topic><topic>Immunology</topic><topic>Immunology in the medical area</topic><topic>lipopolysaccharide</topic><topic>Lipopolysaccharides - immunology</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Medical and Health Sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicinska och farmaceutiska grundvetenskaper</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology in the medical area</topic><topic>Mikrobiologi inom det medicinska området</topic><topic>Original Article</topic><topic>outer-membrane</topic><topic>outer-membrane protein</topic><topic>Pharmacology/Toxicology</topic><topic>protein</topic><topic>Proteins</topic><topic>Proteus Infections - immunology</topic><topic>Proteus mirabilis</topic><topic>Proteus mirabilis - chemistry</topic><topic>Proteus mirabilis - immunology</topic><topic>Serum - chemistry</topic><topic>Serum - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaca, Wiesław</creatorcontrib><creatorcontrib>Arabski, Michał Ph.D</creatorcontrib><creatorcontrib>Fudała, Rafał</creatorcontrib><creatorcontrib>Holmström, Eva</creatorcontrib><creatorcontrib>Sjöholm, Anders</creatorcontrib><creatorcontrib>Weintraub, Andrej</creatorcontrib><creatorcontrib>Futoma-Kołoch, Bożena</creatorcontrib><creatorcontrib>Bugla-Płoskońska, Gabriela</creatorcontrib><creatorcontrib>Doroszkiewicz, Włodzimierz</creatorcontrib><collection>AGRIS</collection><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection (ProQuest Medical & Health Databases)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Lunds universitet</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Archivum Immunologiae et Therapiae Experimentalis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaca, Wiesław</au><au>Arabski, Michał Ph.D</au><au>Fudała, Rafał</au><au>Holmström, Eva</au><au>Sjöholm, Anders</au><au>Weintraub, Andrej</au><au>Futoma-Kołoch, Bożena</au><au>Bugla-Płoskońska, Gabriela</au><au>Doroszkiewicz, Włodzimierz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</atitle><jtitle>Archivum Immunologiae et Therapiae Experimentalis</jtitle><stitle>Arch. Immunol. Ther. Exp</stitle><addtitle>Arch Immunol Ther Exp (Warsz)</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>57</volume><issue>5</issue><spage>383</spage><epage>391</epage><pages>383-391</pages><issn>0004-069X</issn><eissn>1661-4917</eissn><abstract>Introduction Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent manner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R mutant strain were used to study the C3 conversion. Materials and Methods The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium dodecyl sulfate gel electrophoresis. Results The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P. mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S 1959 strain. Conclusion Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.</abstract><cop>Basel</cop><pub>Basel : SP Birkhäuser Verlag Basel</pub><pmid>19707721</pmid><doi>10.1007/s00005-009-0043-8</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0004-069X |
ispartof | Archivum Immunologiae et Therapiae Experimentalis, 2009-10, Vol.57 (5), p.383-391 |
issn | 0004-069X 1661-4917 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_556241 |
source | Springer Link |
subjects | Bacteria Bacterial Outer Membrane Proteins - immunology Bacterial Outer Membrane Proteins - isolation & purification Bacteriology Basic Medicine Biomedical and Life Sciences Biomedicine complement Complement Activation - drug effects Complement Activation - immunology Complement C3 - immunology Complement System Proteins - immunology Humans Immunologi inom det medicinska området Immunology Immunology in the medical area lipopolysaccharide Lipopolysaccharides - immunology Lipopolysaccharides - pharmacology Medical and Health Sciences Medicin och hälsovetenskap Medicinska och farmaceutiska grundvetenskaper Microbial Sensitivity Tests Microbiology in the medical area Mikrobiologi inom det medicinska området Original Article outer-membrane outer-membrane protein Pharmacology/Toxicology protein Proteins Proteus Infections - immunology Proteus mirabilis Proteus mirabilis - chemistry Proteus mirabilis - immunology Serum - chemistry Serum - immunology |
title | Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T09%3A42%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20complement%20activation%20by%20smooth%20and%20rough%20Proteus%20mirabilis%20lipopolysaccharides&rft.jtitle=Archivum%20Immunologiae%20et%20Therapiae%20Experimentalis&rft.au=Kaca,%20Wies%C5%82aw&rft.date=2009-10-01&rft.volume=57&rft.issue=5&rft.spage=383&rft.epage=391&rft.pages=383-391&rft.issn=0004-069X&rft.eissn=1661-4917&rft_id=info:doi/10.1007/s00005-009-0043-8&rft_dat=%3Cproquest_swepu%3E67606498%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c543t-994651401add656210f29861ae2706fa0457a1bb405f0e76b5b0ea6934e5bf0a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=879089651&rft_id=info:pmid/19707721&rfr_iscdi=true |